NewsWatch: Moderna and SpaceX highlighted by a fast-growing U.S. fund traded in London

admin 4 years ago No Comments

This post was originally published on this site

Baillie Gifford U.S. Growth Trust devoted much of its half-yearly report to talking up the prospects of biotech Moderna and rocket launcher SpaceX, two of its investments that helped lift its net asset value surge during the time frame.

Prev Article Next Article

Dow Jones Newswires: Rentokil Initial to buy Terminix for $7 billion

admin December 14, 2021

Futures Movers: Oil rises as U.S. production worries linger, OPEC boosts 2022 demand outlook

admin September 13, 2021

The Wall Street Journal: Alibaba and Tencent consider opening up their ‘walled gardens’

admin July 14, 2021

Therese Poletti’s Tech Tales: AI stole the show this year, but earnings will drag Wall Street back to reality

admin October 17, 2023

: Kaixin Auto stock pulls back after a ‘surprise’ rocket ride higher

admin October 20, 2020

: NBA’s Golden State Warriors become first pro sports team to release its own NFTs

admin April 27, 2021

About The Author

admin

in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

By signing up above you will receive the Daily Buzz Offers newsletter and 3rd party advertisements. Expect up to 5 messages per week from us. You can unsubscribe at any time at the bottom of any of our emails.

Related Posts

About The Author

admin